Sandra Koseoglu

591 total citations
11 papers, 384 citations indexed

About

Sandra Koseoglu is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Sandra Koseoglu has authored 11 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Infectious Diseases and 3 papers in Pharmacology. Recurrent topics in Sandra Koseoglu's work include Pneumonia and Respiratory Infections (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Sandra Koseoglu is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). Sandra Koseoglu collaborates with scholars based in United States, Australia and United Kingdom. Sandra Koseoglu's co-authors include Paul T. Kirschmeier, Ahmed A. Samatar, C. Chandra Kumar, Terrill K. McClanahan, Eric A. Gustafson, Stuart Black, Zhuomei Lu, Luquan Wang, Suxing Liu and Asra Mirza and has published in prestigious journals such as Journal of Biological Chemistry, Vaccine and The Pediatric Infectious Disease Journal.

In The Last Decade

Sandra Koseoglu

11 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Koseoglu United States	8	220	138	76	56	41	11	384
Mehrad Tavallai United States	11	213 1.0×	129 0.9×	80 1.1×	23 0.4×	46 1.1×	15	376
Swapna Chaudhuri India	15	229 1.0×	137 1.0×	46 0.6×	57 1.0×	63 1.5×	49	553
Christine Frantz Canada	8	211 1.0×	152 1.1×	53 0.7×	35 0.6×	40 1.0×	9	453
Kazuo Umezawa Japan	10	199 0.9×	114 0.8×	64 0.8×	12 0.2×	64 1.6×	13	394
Penghui Jia China	10	165 0.8×	66 0.5×	85 1.1×	32 0.6×	30 0.7×	21	342
Walter Beerheide Singapore	10	212 1.0×	79 0.6×	94 1.2×	22 0.4×	31 0.8×	11	428
Daniel Mazal Uruguay	9	388 1.8×	108 0.8×	48 0.6×	13 0.2×	34 0.8×	13	583
Juan Mo China	11	277 1.3×	97 0.7×	42 0.6×	21 0.4×	113 2.8×	33	483
Kensei Komatsu United States	11	151 0.7×	95 0.7×	55 0.7×	17 0.3×	60 1.5×	16	359
Samantha S. Dykes United States	12	168 0.8×	84 0.6×	66 0.9×	16 0.3×	41 1.0×	16	329

Countries citing papers authored by Sandra Koseoglu

Since Specialization

Citations

This map shows the geographic impact of Sandra Koseoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Koseoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Koseoglu more than expected).

Fields of papers citing papers by Sandra Koseoglu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Koseoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Koseoglu. The network helps show where Sandra Koseoglu may publish in the future.

Co-authorship network of co-authors of Sandra Koseoglu

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Koseoglu. A scholar is included among the top collaborators of Sandra Koseoglu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Koseoglu. Sandra Koseoglu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Mngqibisa, Rosie, et al.. (2025). A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections. The Pediatric Infectious Disease Journal. 44(6). 533–538. 1 indexed citations

Li, Junjie, Wei Feng, Xiang Peng, et al.. (2024). A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP). International Journal of Infectious Diseases. 153. 107357–107357. 1 indexed citations

Lupinacci, Robert, Richard Rupp, Orasri Wittawatmongkol, et al.. (2023). A phase 3, multicenter, randomized, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants (PNEU-PED). Vaccine. 41(5). 1142–1152. 26 indexed citations

Lupinacci, Robert, Richard Rupp, Orasri Wittawatmongkol, et al.. (2022). 336 A phase 3, multicenter, randomised, double-blind, active-comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of a 4-dose regimen of v114 in healthy infants (PNEU-PED). A204.1–A204. 2 indexed citations

Labroli, Marc, John P. Caldwell, Christine Yang, et al.. (2016). Discovery of potent wall teichoic acid early stage inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(16). 3999–4002. 9 indexed citations

Yang, Shu‐Wei, Jianping Pan, Christine Yang, et al.. (2016). Benzimidazole analogs as WTA biosynthesis inhibitors targeting methicillin resistant Staphylococcus aureus. Bioorganic & Medicinal Chemistry Letters. 26(19). 4743–4747. 11 indexed citations

Mann, Paul A., Catherine A. McLellan, Sandra Koseoglu, et al.. (2014). Chemical Genomics-Based Antifungal Drug Discovery: Targeting Glycosylphosphatidylinositol (GPI) Precursor Biosynthesis. ACS Infectious Diseases. 1(1). 59–72. 65 indexed citations

Koseoglu, Sandra, et al.. (2007). AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biology & Therapy. 6(5). 755–762. 71 indexed citations

McClanahan, Terrill K., Sandra Koseoglu, Eric A. Gustafson, et al.. (2006). Identification of overexpression of orphan G protein-coupled receptor GPR49 in human colon and ovarian primary tumors. Cancer Biology & Therapy. 5(4). 419–426. 150 indexed citations

10.

Lu, Zhuomei, Zhizhang Yin, Linda James, et al.. (2004). Development of a Fluorescence Polarization Bead-Based Coupled Assay to Target Different Activity/Conformation States of a Protein Kinase. SLAS DISCOVERY. 9(4). 309–321. 7 indexed citations

11.

Samatar, Ahmed A., Luquan Wang, Asra Mirza, et al.. (2002). Transforming Growth Factor-β2 Is a Transcriptional Target for Akt/Protein Kinase B via Forkhead Transcription Factor. Journal of Biological Chemistry. 277(31). 28118–28126. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact